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ABSTRACT 
Several 1-alkylbenzoylpyridinium halides containing 
alkyl side chains of ons to fifteen carbons wers screen e d 
for pharmacological activity. A comparison of potency was 
based on the ability to produce mortality in 50 percent of 
mjce (LD5D)~ 
The following parameters ~ere investigated in a 
select number of compounds representative of the series: 
acute intraperitoneal LD50 in rats; EDSO (hypo tensive) in 
rats; effects on the autonowic nervous system of anes-
thetized cats and dogs as indicated by alteratio11s in 
blood pressure; effects en the nictitating membrane in 
anesthetized cats; direct effects upon blood vessels 
employing hind quarter perfusion in intact rats; effects 
on the isolatec perfused guinea pig heart. 
In mice the trend of acute intraperitonsal toxicity 
was biphasic. ~he methyl salts were the least to xic , 
while toxicity sharply increased with the ethyl salts. 
As the carbon substitution incre ased to seven, toxicity 
decreased. Further carbon substitution led to a progres-
sive i~cre ase in toxicity. Although fewer compounds were 
tested in rats, the LD50 1 s approximately paralleled those 
of the miceo 
3-Benzoyl-1-ethylpyridinium iodide (3-C2-I), 
i 
3-benzoyl-1-octylpyridinium bromide (3-CB-Br), and 
3-benzoyl-1-pentadecylpyridinium bromidE ( 3-C15-Br) 
produced hypoten s ive effects in aneEthetized rats. The 
ED50 ( hypotensive) i~creased in that order. 
Demonstration of hypot e nsive responses in anes-
thetized rats led to an investigation of the mechanism of 
t his action& Decreas e d responses to carotid occlu s ion 
and vag a l stimulation 2nd increesBd respo nse s to inject ed 
epinephrine in anesthetized cat s and dogs suggested th a t 
the 3-C2-I and 3-CB-Br exerted a hypotensiv e responEe 
through gang lioplegia. 3-CB-Br was more potert than 
3-C2-I. rurth er testing of 3-C15-~ was discontinued at 
this time as respiratory failure followe ~ by cardia c 
arrest occurred, app a rently due to excessive qu an titi es of 
f luid in the respiratory passages. 3-Benzoyl-1-dodecyl-
pyridinium bromide also elicited this response. 
The ability of 3-C2-I and 3-CB-Br to block the 
normal response of the rictit a ting membrane in ca ts by 
electrical stimclation of the pre~ang lionic cervical 
sym~ath e tic nerve was test ed~ 3-CB-Br was ~ore potent th a n 
3-C2-I in this test. 
The flo w rates of perfusions of th e hind quarter 
vascul ature of th e intact rats were unaffecte~ by doses 
up to the equi va l ent ED 50 (hypot ensive )e 3-C2-I an d 
3-C B-Br sl1o we d card iodepressa nt and cardiotoxic effects 
on the i solated g~inea pig heart, although a direct do se 
ii 
effect relationship could not be shown. 3-CB-Br was more 
potent than 3-C2-I in producing cardiac arrest. 
The results of these experiments support the 
hypoth esis that 3-C2-I and 3-CS-Br exart a hypotensive 
effect thro ugh ganglioplegia 1 un abet ted by direct vaso-
dil ation. A depressant action on the heart may contribute 
to the hypotension induced by ganglioplegia. 
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Io INTRODlCTION 
Some 1-alkyl-3-benzoylpyridinium halidee were 
synthesized in 1967 by the Departmert of Pharmaceutical 
Chemistry, University of Rhode Island, College of Pharmacy, 
Kingston, Rhode Islando The most distinctive chemical 
feature of pharmacological interest of th ese compcunds is 
the quaternary ammonium moiety. Although these co~pouncis 
were designed ES molluscicidal agents, it was felt that 
they might exhibit properties similar to other quaternary 
ammonium c~mpounds, such as ganglioplegia, skeletal 
muscle relaxation, or other autonomic effectso 
The possibility of 5ffects en the cardiovascular 
syst em and autonom~c nervous system led to the screening 
of th ese compounds with various tests de signed to show such 
actions. 
The r esults of this study may indicate a possible 
therapeutic value of these agents as well as relative 
dan ger or safety when e~plciyed as molluscicidal agents. 
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II. REVIEW QC THf LITERATURE 
In the course of the nineteerth century, which 
encomp2sses the era of development and growth of the field 
of synthetic organic pharmaceuticals, many natural products 
WEre i solated 1 purified and their chemical structure 
det ermined. When it becam e apparent that certa in similar 
stru ctural moieties were somEtimes present in compounds 
po ssessing related pharmacocynamic activity, this observa-
tion was seized upon as the only available guide for future 
research. The modification cf the structure of a promising 
d~ug compound is still the wain approach to producing new 
drugs. Since structural . variations in a compound may not 
alter all actions of the drug equally, the therapeutic 
utility of a compound may be enhanced by developing a 
cong ener whose therapeutic index is greater than that of 
the parent compound. Physical changes ·a ccomp a nyini; 
structural variations may bring i mprovemerts in solubility, 
vol atilit y, color and odor which may increEse the utility 
of a given compound (B urger, 1960; Wilson and Gisvold, 
1962). Therapeutica lly and experimentally valuab le drugs 
hav e been develop e d which are structurally related antag-
on i s t s o f o t her . d r u r;.s ( Ha r t tl_a 1 • , 1 9 4 4 ) or o f ch em i ca 1 s 
i mportant in bioche mica l or physiological function (Farber 
et al., 1948 ; Symposium, 1954) •. · 
7 
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It has been hoped that the action of different drugs 
might be explained on a unified basis thus allowing forma-
t ion of general principles guiding the rational development 
of utilitar·ian new drugs with predicted and select pharmaco-
logical properties. Largely unsu~cessful attempts were 
made to relate a particular functional group to a particular 
pharmacological effect ( Burger, 1958 ) . Many compounds un-
related chemically elicit the same pharmGcologicel action, 
particularly amen£ the CNS depressants ( Burger, 1960 ) . 
Conversely, many compounds containing the same functional 
group show a divergence of action, such as the sulfonamides 
which have bacteriostatic ( Northey, 1948), hypoglycemic 
(L oubatieres et ale, 1955; Editorial, 1956) 1 diuretic 
(Krsbs, 1948; Miller et alo 1 1 ~50 ) and artificial sweet-
ening properties ( Schutz et al., 1957 ) . 
The difficulty in finding a relationship among 
c ompounds having similar biological actions but different 
chemical structures, and the converse, does not negate 
t he significa~ce of structure activity relationships. To 
t he contrary, it emphasizes the complexities of biological 
systems, the limitations of our kno~ledge of the basic 
mechanis~s of drug action and that dregs may produce 
overtly similar responses by mo r e than one mechar.ism. 
Even the more advanced theories of isosterism 
( Erlenmeyer et al., 1932; Friedman, 1951) and interference 
with drug metabolism (Bradys 1955) have not shown 
9 
regularities in st~ucture activity relationships that 
c ould be transferred indiscriminantly from one group of 
c ompounds to the next. However, the most pronounced 
r egularities could be expected in a series of closely 
analogous compounds. This is demonstrated in an homologous 
s eries since the regularities ~esulted from gradual physical 
changes ( Ferguson, 1939; Hansch, 19E6 ) . 
" In 1869? Crum-Brovm and Fraser observed that 
t ertiary amines with varying pharmacological properties 
t ended to show similar properties when quaternized 11 ( Wilson 
a nd Gisvold p. 4, 1 962)0 Thus, although the literature 
r eports no pharmacology of the 1-alkyl-3-benzoylpyridinium 
halides , the presence af a quaternary ammcnium group might 
i mpart known characteristics of other quaternary com~ounds. 
Among the ~uaternary aramonium compounds are anti-
bacterial agents (L.awrence, 1958) ( disinfectants, anti-
s eptics or sanitizers ) such as benzalkonium chloride and 
cst ylpyridinium chlorideo Other _quaternary ammcnium 
c ompounds have anticholinergic properties which have found 
use es antisecretory , antispasmodic and antiulcer drugs 
( Bachrach, 1958; Kirsner ~t ·a1. , 1953 ) . Many of these 
drugs are quaternary ammonium de rivatives Gf atropine, 
scopolamin e , and papa verine. Curariform activity is 
elicited by certain quaternar y ammonium compounds ( Barlow 
et al., 1948 ; Cast illo .£.L21.•, 1950) l whi_le othors, such 
as necstigmine, are cholinesterase inhibitors or curare 
antagonists (Acheson et al., 1946; Wien et al., 1952)0 
Althoug h a superficial inspection supports the 
assumption of a diverge nce of biological actir.n among the 
quaternary ammonium salts, the common factor is the 
structural resemblance to acstylcholine, more specifical ly, 
the quaternary ammonium group. Since acetylcholine 
mediates nervous trans111ission at various sites in the bo_dy 
( Triggle, 1965), a structural congener of acetylcholine 
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msy mimic its act ion at these various sites, may antagonizs 
acetylcholine or may inhibit cholineeterase 1 which de-
activ ates acetylcholine. If its absorption and distribution 
permits, it may exhibit those c:~ctions at more than one site. 
Since multiplicity of pharmacodyn am ic behavior interferes 
with the utility of many of these drugs ( Issekucz 1 1954)r 
structural modifications may lead to a higher specificity 
of actior.. 
III. INVESTI GATION 
A. OBJECTIVES 
The overall objective of thi s investigation was to 
evaluate th e ph arma cology of some benzoylpyridinium salts 
1n mc:1mmals. 
The specific object ivss of this investi gation were: 
1. To screen a series of synthetic benzoylpyri-
dinium s~lts for pharmacological activity~ 
2. To relate the activity to the structural 
arrangement of thH compounds screened. 
3. To study in detai l a select number of these 
compounds in an attempt·to determine the pharmacological 
site of action. 
B_. COMPOUNDS 
11 
The follo~ing compounds were used in this investiga-
tion and will hereafter be denoted by"the ebbreviat ions 
shown in parenthesis : 3-ben zo yl-1 -met hylpyridinium iodide 
( 3-C1-I); 3-benzoy l-1-eth ylpyridinium iodide (3-C2-I); 
3-benzoyl - 1 -propy~pyridinium iodide (3-C3 - I); 3-benzoyl-
1-butylpyridini um bromide (3-C 4-Br); ~-benzo yl - 1-pentyl­
pyridinium bromide ( 3-C5-Br ); 3-benzoyl-1-heptylpyridinium 
bromi de (3-C?- Br ); 3-benzoyl-1-octylpyridinium bromide 
(3-C B-Br ); 3-benzoyl-1-nonylpyridinium bromide (3-C9- Br ); 
3-benzoyl-1-decy l pyridinium bro~ide (3-C10- Br); 3-benzoyl-
12 
1-dodecylpyridinium bromide ( 3-C12-Br); 3-bsnzoyl-1-penta-
decylpyridi niu~ bromide (3-C15-Br ); 4-benzoyl-1-methyl-
pyridinium iodide ( ~-C 1~I'; and 4-benzoyl-1-ethylpyridinium 
iodid e (4 - C2-l)o 
All of th e compounds were solids and most of them 
wer e fre ely soluble in water. All compounds were admin-
ister ed in aqueous solutiono 
The compounds were reported to be pure excspt for 
3-C2-I , which was 91 percent pure~ The doses reported 
throughout the investigation were uncorrected for the 
impu rity, i.e. 1 the doses wsre reported as if the compound 
were pure., 
Co ANIMP.LS 
1. Mice: Male and female albir;o mice of the Charles 
River strain 1 were eIT'ployed for the acute toxicity studies. 
2o Rats: Male and female albino rats of the Charles 
Riv er strain 2 WETS employed for the acute toxicity studies 
and the rind leg perfusion studies, while male 2lbinc rats 
of the same strain were employed for the blood ~ressure 
studieso 
3. Guin ea pigs: Mongrel guinea pigs of either sex 
were eIT'ployed for all isolated heart studieso 
4. Cats: Mongrel ca ts of either sex were employed for 
1 Ch arles River Breeding Farms, North Wilmin~ton , Mass. 
2 Ibid., 
blood pressure studies and for the nictitating membrane 
prep arations .. 
5. Dogs: Mongrel dogs of either sex wsrs employed 
for blocd pressure studies. 
D. INSTRU MENTS 
The E&M Physiograph 1 and its accessories were used 
for all electronic recordings. 
E. EXPERIMENTAL PROCEDURES AND RESULTS 
The investigation was divided into six sections: 
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1. Th e acute intraperitoneal toxicity of the 
1-olkyl-3- and 1-alkyl-4-benzoylpyridinium halides in mice; 
th e acute intraperitoneal toxicity of 3-C2-I, 3-C4-Br, 
3-C5-Br, 3-CB-Br and 3-C15-Br in rats. 
2. The effects of 3-C2-I, 3-CB-Br and 3-C15-Br 
upon the blood pressure of rats. 
3. The effects of 3-C2-I, 3-CB-Br, 3-C12-Br and 
3-C15-Br upon the autonomic nervous system employing 
c2rdiovascular tests in cats and dogs. 
4. The Effects of 3-C2-I and 3-CB-Br upon the 
nictitating membrane of the cat. 
5. Th e effects of 3-C2-I and 3-CB-Br upon the 
hind quarter vasculaturs of the intact rat. 
6. The effects of 3-C2-I and 3-CB-·Br upon the 
i solated guinea pig hEar t. 
1E&M In st rumeGt Comp an y, Inc., Houston, Texas 
1. ~~ Intraperitoneal Toxicii.'i 9i_ the 1-Alkyl -3- ~ 
1-Alkyl-4-benzoylpyridiflium Halides in Mice and Rats 
a ) Ex perimental Procedures 
Fifty albino mice weighing 19g to 40 g and fifty 
albino rats weighing 150 g to 400 g were divided into five 
groups ec.ch cc0 ntaini ng equal numbers of both sexes 1 exc_ept 
wh E1re noted., 
In dividual drugs, 20 mg/ml as the salt or suitable 
dilu t io ns thereof prepared in distilled water , were 
administered intraperitoneall y. The enimals were observed 
fo r 24 hours and general symptoms and tim e of dec th re-
co rded. No animal was used more than once throughout the 
entire stcdy. 
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Th e doses were space~ in approximate ly logar ithmic 
int ervelso Dos age was adjusted according to the results 
obt ained, in order to determine the do se of a particular 
c om~oun~ that would produce de at h in 50 percent of the 
animals (L D50 ) o The dose and rESRonse were subjected to the 
Li tchfield 2nd Wilcoxon (1 948 ) method of evaluatiflg doee-
effect experiments. Th e results were plotted and the LD50 
graphic2lly calculated. 
The compounds were compared on the basis of their 
mg/k g LD 50 and their mM/kg LD 50. 
b) Results 
The results incl ude the following: . 
(1) A comparison of the LD50 of the various 
compcunds (T able 1). 
(2) A comparison of tl1e mM LD50 versus the rumber 
of carbons in the side chain (Fig: 1). 
(3) The compounds cont a ining from one to eight 
carbors in the alkyl side chain were found to be short 
acting , as ceeth or recovery occurred in 1 hour. Higher 
members of the series were found to be longer acting , with 
death or recovery requiring a 24 hour period. 
The gsneral symptGms produced ty al l the drugs in 
both species were the same, i.e., slu~gishness, decreased 
acti vity, mydri a sis, loss of righting reflex as death 
approached , an d dyspnea followed by convulsions and death. 
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TABLE 1 .. A compar i son of the LD50 of some 1- alkyl - 3- and 1- alkyl - 4- benzoylpyridinium 
halides in mice and rats 
0 e !Yi ice Rats rQr 3 -rQY- R X LD50 + 0.95 LD50 + 0.95 
Confidence Limitsa Confidence Limitsa 
Isomer R x ( mg / kg) (mlYl/kg) ( mg/kg) ( mlYl /kg) 
3 CH3 I 84 (73-104) 0.285 
3 C2H5 I 46 (39- 55) o.136 127 (113-142) 0.375 
3 C3 H7 I 55 (51 - 60) o.156 
3 C4H9 Br 86 (79- 94) 0.269 180 (1 58 - 2.05)b 0.563 
3 C5 H11 Br 90 ( 84 - 96) 0.270 227 (207 - 249)b Oo680 
3 C7H15 Br 103 (97 - 109) . 0.284 
3 C8H17 Br 90 (78-110) 0 .. 244 40 ( 36 - 44) 0.106 
3 C9H19 Br 67 (59- 76) 0.156 
3 C10H21 Br 46 (48- 53) 0.114 
3 C12H25 Br 38 (33- 44) 0 .. 088 
3 C15H31 Br 3,g ( 33- 44) Oo080 44 ( 31 - 63) 0 .092 
4 CH 3 I 110 (94-129) Do338 
4 C2H5 I 15 (11- 21) Do044 
aCalculated From the Litchfield and Wilcoxon ( 19 48 )'method., ~ 
°' 
bThrae groups of 6 animals were used instead of usual 5 groups of 10 animals. 
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Fig. 1. Strccture Activity Relationship of the 1-Alkyl-3-benzoylpyridinium Halides~ 
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2. Effects of 3-BeD3.9.:d.=J-ethy lpyridini um Iodid e (3-C2 - I), 
3-B enz oyl-1-oct ylpyrid in ium Bromide ( 3-CB-Br ) and 
3- Ben .z o y 1-1 -p 8 n t ad E: c y 1 p yr i d i n i um 8 r om i de ( 3- C 1 5 ·· 8 r ) 
.QD_ the Blood Pr essure .Q.f. Rats 
a ) Experim~nta l Procedures 
Th e effects of the compour.ds on the blood pressur e of 
mal e albino rats we i ghing between 300 g and 475 g were 
recorded wanometri ca lly by direct cannulation of the l eft 
carotid artery~ A normal saline, fluid bridge in tygon 
tubi nq c onnected the cannula to a mercury manometer. 
Blood pressure responses were recorded cm a s] owly moving 
s ~oked kymogrciph. 
Rats were anethetized with urethane , 1 ~2 g/k ~ of a 
fr eshly prep a rec 20 percent solution, administered in tra-
peritoneall y via the ri ght f emora l ve in. To prev e nt 
clottin g, heparin sodium 1 0 .1 ml of a 1:10 .ooc solution , 
wa s ad~inistered to each rat prior to cannulation . A 
similar conc en tration of hep ar in s odiu~ was placed i nt o the 
ca nnul a. 
A minimu m of 10 minutes ~as a llo~~d to elapse prior 
to dr ug administration to perm it sta bi li zat ion of th e blood 
pr essure. One drug was sdministered per anima l and no more 
th an a tot a l of 4 inj ect ion s were a dminist sred to on e anima lo 
Foll owing each inj ect ion the blood pressure was a llo wed to 
return to no rmal be fore a second inj ect ion ~as made. 
Doses were adjusted to detGrmine the dose of a 
compound th at would produce an approximate 50 percent 
decre ase in blood pressure~ The doss and response was 
subjected to ths Litchfi eld an~ Wilcoxon (19~8) method of 
evaluating dose-effect experiments. The results were 
plotted and the ED50 (hypot ensive ) calculated. 
The compounds were co~pared using the following 
indices of activity: 
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(1) The percent decrezse in blood pressure produced 
by different doses of the compounds. 
(2) The duration of the hypotensive effect, i.e., 
time elapsed before the arterial blood pr essure returned 
to 90 percent of the normal blood pressure. 
(3) The dose of the compound required to produce 
a 50 ~ercent decrease in arterial blood pressure, i.e., 
ED50 (hypotensive). 
b) Results 
The results includ e the followi~g: 
(1) Effects of 3-C2-I, 3-CB-Br and 3-C15-Br on 
the arterial blood pressure of male albino rats ( Tables 2 
to 4). 
( 2) A comparison of the effects of 3-C2-I, 3-CB-Br 
and 3-C15-Br on the arterial blood pressure of male albino 
rats (T able 5). 
TABLE 2. Effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I) on the blood pres-
sure of rats 
Dose Number of Mean % Drop Duration of 
(mg/kg) Trials in Blood Drop 
Pressure (fYlean and Range) 
.±. S.D. (Min.) 
2,0 2 12 .±. 2 3.0 (2.7-'.1.3) 
3.0 2 15 .±. 5 3.2 (3.0-3.4) 
6.0 1 22 3.2 
10 .. 0 3 26 .±. 3 3.4 (2.7-4.0) 
20.0 4 34 .±. 2 3 .. 3 (3,.0-4.2) 
25.0 4 40 .±. 7 3,6 (3.3-4.0) 
30.0 4 45 .±. 4 3.3 (2.5-3.6) 
N 
0 
TABLE 3~ Effects of 3- benzoyl - 1- oc t yl p yridinium br omide (3 - C8 - Br ) on the blood pres -
sure of rats 
Dose Number of Mean % Drop Duration of 
(m g/ kg ) Trials in Blood Drop 
Pr.essure (!Ylean and Range) 
+ S .. Do (!Ylin.) 
-· 
2n5 3 34 ±. 1 3.6 (3.0-4.2) 
5 .0 6 39 ± 3 4.4 (3.2 - 5.2) 
7 .. 5 3 43 ± 3 5.0 (4.0 - 6.0) 
10.0 4 48 ± 3 6 •. 9 (6.0 - 8 .2) 
N 
_,_ 
TABLE 4. Effects of 3-benzoyl-1-pentadecylpyridinium bromide (3-C15-Br) on the blood 
pressure of rats 
Dose Number of !Ylean % Drop Duration of 
( mg/kg) Trials .in Blood Drop 
Press ure (!Ylean and Range) 
.±. S.D. (!Ylin.) 
1.0 2 24 .±. 1 3.5 (3.0 - 4.0) 
2.0 2 32 .±. 1 7.3 (4.6-10.0) 
3.0 2 42 ±. 1 10.8 (5.6-16.0) 
5.0 1 43 6.2 
7.0 2 48 .±. 1 13.5 (9.0-18o0) 
10.0 1 54 20~0a 
8 Did not recover to 90 porcent of normal within 20 minutes; terminated .. 
N 
N 
TASLE 5. A comparison of the ED50 (hypotensive) of the 1-alkyl-1-benzoylpyridinium 
halides on the blood pressure of rats 
Compound 
3-Benzoyl -1-ethylpyridinium 
iodide (3-C2-I) 
3 - Benzoyl-1-octylpyridi~ium 
bromida (3-C8-Br) 
3- Benzoyl -1-pentadecylpyri -
diniu m bromide (3-C15-Br) 
Total 
Trials 
20 
. 16 
10 
Calculated 
ED50a 
(mg/kg) 
52.0 
14.0 
8.1 
ED50 
(m !Yl /kg) 
0.153 
0~037 
0.017 
aDe rived from the Wilcoxon and Litchfield (1948) method of evaluating dose -
effect experiments~ 
N 
t.N 
3. Effects .Qf 3-Benzoyl-1-ethylpyridinium Iodide (3-C 2-I ), 
3-Ben zoyl-1-octylpyridinium Bromide ( 3-CS-Br ), 
3-Benzoyl-1-dodecylpyridinium ]romid~ (3-C12-Br) 
and 3-Be nzoyl-1-pentadecylpyridinium Bromide 
(3- C15-Br) .Q.!J. Four Cardiovascular Tests in the 
W and the .Q.£g 
a) ExR erimen tal ££ocedures 
Mor~rel cats of either sex weighing 2.5 to 3.5 kg and 
mongrel dogs of either sex weighing 17 .5 to 19. 5 kg were 
anesthetized with sodium pe ntobarbital, 35 mg/kg of a 3a5 
percent solution, administered intraperitoneally and intra-
veno usly, respectively~ Following cannulation of the left 
femor 21 l artery, the blood pressure v1a s recorded on a cali-
brated Physio~raph. The cannula was connected via a fluid 
brid ge of normal saline to a Bourdon typ e pressure trans-
duc ero All injections were mad8 into the right femoral 
vein via a cannula connected to e buret containing norm a l 
saline used to displace the drug. A trach eo tomy was per-
formed as part of thr rorm~l procedure. The commcn carotid 
arteries were isolated and a Joose ligature pass~d under-
neath each. When performing a bilateral carotid occlusion, 
the ligatur~ wes lifted and 2 taped bulldog clamp secured 
caud a d to the bifur cat ior. Care was t aken to avoid 
unnecessary stretching of the arter y.. Th e cer vica l portions 
of th e vagal nerves were then isolated, li gated and severed 
cra niad to th e ligature. Following stabilizatio1 of the 
preparation the following tests were performed: 
(1) bilatera l occlusion of the comwon carotids-3 0 
s ec. 
(2) bilateral vagal stimulation- the intensity was 
a djusted to obtain certain percent responses-20 sec. 
( 3 ) epinephrine-the dose was adjusted to obtain 
certain percent responses. 
( 4 ) acetylcholine-the dose was cdjusted to obtain 
certain percent responses~ 
( 5 ) tests compound-the dose ~as adjusted t o obtain 
certain percent responses. 
( 6 ) repeat test ( 1 ) • 
(7) repeat test ( 2 ) 0 
( 8 ) r epeat test ( 3) . 
(9) repeat test ( 4 ) •. 
It should be noted that additional doses of a com-
p ound were give~ when the effect was not of sufficient 
duration to complete the series of tests~ 
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Th e percent change i n blood pressure produced by 
e a c h of t he test procedures before and after administration 
of a compound was the index of activity studied. 
b ) Results 
The results include the follo wing: 
( 1 ) Changes induced in four cardiovascul a r tests 
by 3-C2-I an~ 3-CS-Br in the ca t and the dog ( Tab l es 6 to 
1 1 ) • 
( 2 ) A comparison of the changes induced in four 
cardiovascular tests by thess compo~nds ( Table 12 ) o 
( 3 ) Whan 3-C12-Br and 3-C15-Br ware administered 
t o cats , the blood pressure was low3rede Death soon 
f ollowed, apparently dua to respiratory impair~e~t fro~ 
l arge amounts af f lu:d ~n the lungs. The secretion of 
26 
f luid did not result from the use of acetylcholine as it also 
appeared when these compounjs were administered to cats 
prepared in the same surgical manner but which had not re-
ceived any prior drugso 
TABLE 6. Effects of 3-ben zoyl -1-ethylpyr idinium iodide (3-C2- I ) on four car di ovas-
cular tests in the cat: cat 1 
Test Dose Change in % Change in 
(units/kg) Blood Pressure Blood Pressure 
(Ori(inal-P eak ) 
. mm Hg.) 
Bilateral carotid 
occlusion (30 sec. ) 120-190 +58 
Bilateral va(al 
stimulation 20 sece) 120- 80 -3 3 
Epinephrine HC1 6.6 ug 120-1 70 +42 
Ace tyl choline HBr 0.3 ug 130- 75 - 42 
3- C2 - I 20.0 mg 125 -1 05 -1 6 
Bilateral carotid 
occlusion (30 sec.) 10 5-1 10 + 5 
Bilatere.l va(al 
stimulation 20 sec.) 105-105 0 
Epinephrine HCl 6 .. 6 ug 105-160 +52 
Acetylcholine HBr 0.,3 ug 11 0- 70 -3 6 
N 
-.J 
TABLE 7. Effects of 3- bEnzoyl -1-ethylpyridinium iodide (3-C2-I) on four cardiovas -
cular tests in the ·cat: cat 2 
Test Dose Change in % Change in 
(units/kg) Blood Pressure Blood Pressure 
(Dri (inal - Peak) 
mm Hg) 
Bilatera l carotid 
occlusion (30 sec.) 160 - 210 + 32 
Bilateral va(al 
stimulation 20 sec.) 160-130 - 20 
Epinephrine HCl 0.8 ug 160 - 210 + 32 
Acetylcholine HBr 0.2 ug 160-110 - 31 
3-C2-I 6.5 mg 160-12 0 - 25 
Bilateral carDtid 
occlusion (30 sec.) 110- 120 + 9 
Bilate:-al vaaal 
stimulation (20 sec.) 130 - 110 
-
8 
3-C2-I 13. 1 m.g 160 - 80 - 50 
Epinephrine HCl 0.8 ug 80 -1 60 +100 
3-C2-I 130 1 mg 15C - 75 - 50 
Acetylchcline HBr Oo2 ug 70 - 50 - 29 N 
co 
TABLE 8 . Effects of 3-benzoyl-1-ethylpyridi nium iodide (3-C2-I) on four car diovas-
cular tests in the dog: do g 1 
Test Dose Change in % Change in 
( units/kg) Blood Pressure Blo od Pressu re 
(Ori(inal-Peak) 
mm Hg) 
Bilateral carotid 
occlusion (30 sec. ) 150-185 +23 
Bilateral va(al 
stimulati on 20 sec.) 140-100 -28 
Epinephrine HCl 2.5 ug 150-170 +13 
Acetylcholine HBr D.5 ug 130-105 -1 9 
3- C2-I 8.5 mg 135-105 -2 2 
Bilaterel carotid 
occlu~ion (30 sec. ) 130-130 0 
Bilatera l va(al 
stimulation 20 sec.) 130-130 0 
Epinephrine HCl 2.5 ug 130-175 +25 
Acetylcholine HBr 0.5 ug 125-110 - 12 
N 
l.O 
TABLE 9. Effects of 3- benzoyl - 1-o ctyl pyridinium brom i de ( 3-C 8- Br) on four ca r dio-
vascular tests in the cat: cat 3 
Test Dose Change in % Change in 
( units/kg ) Blood Pressure Blood ' Pressure 
(Ori(inal - Peak) 
mm Hg) 
Bilateral carotid 
occlusion (30 sec.) 190- 280 +47 
Bilateral vaoal 
stimulation (20 sec.) 190- 130 - 32 
Epinephrine HC:l 0 .7 ug 180 - 210 + 1'7 
Acetylcholine HBr o. 3 t,.J g 170 - 100 - 41 
3- CB-Br 10 . 6 mg 170 - 80 - 53 
Bilateral carotid 
occlusion (30 sec . ) 90 - 110 +22 
Bilateral vaoal 
stimulation (20 se c. ) 90 - 75 - 17 
Epinephrine HC l D. 7 ug 110 - 180 +63 
Acetylcholine HBr 0,.3 ug 110 - 60 - 45 
03 
0 
TABLE 10. Effects of 3-benzoyl-1-octylpyridinium bromide (3-CS-Br) on four cardio-
vascular tests in the cat: cat 4 
Test Dose Change in % Change in 
(units/kg) Blood Pressure Blood Pressure 
(Ori(inal - Peak) 
mm Hg) 
Bilateral caroti d 
occ lusion (30 sec.) 120-170 +42 
Bi lateral vafal 
stimula~i o n 20 sec.) 120 - 80 · -33 
Epinephrine HC.1 0.8 ug 130-190 +46 
Acetylcholine HBr 0.3 ug 150 - 80 - 47 
3-CS-Br 13.5 rng 150- 80 -47 
Bilateral carotid 
occlusion (30 sec.) 80- 85 +· 6 
Bilatera l vaoal 
stimulati on (20 sec.) 80- 75 - 6 
Epinephrine HCl 0.8 ug 80-140 +75 
Acetylcholine HBr 0,..3 ug 80 - 40 - 50 
CA 
_. 
TABLE 11. EffBcts of 3-benzoyl ~1-octylpyridinium bromide (3-CS-Br) on four cardio-
vas~ul ar tests in the dogs dog 2 
Test Dose Change in % Change in 
(uni ts/kg ) Blood Pressure Blood Pressure 
(Ori(inal-Peak) 
. mm ·Hg) 
Bilateral carotid . 
occlusion (30 sec.) 140-1 75 + 25 
Bilateral va~al 
stimulation 20 sec.) 135 - 85 ·- 37 
Epinephrine HC.1 2o2 ug 135 - 160 + 19 
Acetylcholine HBr 0.6 ug 130-1 00 
- 23 
3-CS - Br 6.7 mg 135 -10 0 - 30 
Bilateral carotid 
occlusion (30 seco) 100- 105 + 5 
Bilateral vaqal 
stimulation (20 sec.) 95 - 95 0 
Epinephrine HCl 2 .. 2 ug 95 - 200 +100 
Acetylcholine HBr 0.6 ug 90 - 70 - 22 
c.N 
N 
TABLE 12. A comparison of the effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I) 
and 3- benzoyl - 1-octylpyridinium bromide (3-CB-Br) 
Animal 
Cat 1 
Cat 2 
Dog 1 
Cat 3 
Cat 4 
Dog 2 
on four cardiovascular tests in the cat and the d~g 
Drug Dose 
(mg/kg) 
None 
3-C2-I 20 .. 0 
None 
3-C2-I 6 .. 5 
None 
3-C2-I 8.,5 
None 
3-C B- Br 10 <> 6 
None 
3-CB-- Br 13 .. 5 
None 
3-C B- Br 6.7 
BCD 
++ 
0 
++ 
0 
++ 
0 
++ 
+ 
++ 
0 
++ 
0 
a,b Blood Pressure Changes 
BVS 
0 
0 
0 
0 
.0 
EPI 
.+ .+. 
++ 
.+.+ 
+++ 
. +.+ 
+++ 
.. .+.+ 
+++ 
.++ 
+++ 
++ 
+++· 
ACH 
aSymbols: +, rise; ++, marked rise; +++, severe rise; - , fall; -- 1 marked 
fall; 0 1 no changeo 
b Abbreviations: BCD, bilateral carotid occlusion; BVS, bilateral vagal 
stimulation; EPI, epinephrine; ACH, acetylcholina~ 
(.,.l 
(.,.l 
4 • E f f e ct s · o f .3- Be n z o y 1-1 - et .b.1JB yr i d i n i um I o d i de ( 3- C 2 - I ) 
Nictitati.Q_g Membrane £f.. .i!Je Cat 
a) Experimental Procedures 
Mongrel cats of either sex weighing 2.5 to 3.5 k9 
were anesthetized with a 3.5 percent solution of pentobarbital 
35 mg/kg, administered intraperitoneally~ A tracheotomy ~as 
perfo rmed as part of the normal procedureo Following cannu-
lation of the left femoral artery, the blood pressure was 
record ed on a calibrated Physiograph. Th e cannula was 
connected via a fluid br id ge of normal saline to a Bourdon 
type pressure transducer. All injections wEre made into the 
right femoral vein via a cannula connected to a buret con-
taini ng normal saline used for displacement of the drug. 
The preganglionic cervical sympathetic nerve was 
isolated , ligated and severed caudad to the li gature~ The 
superior cervical ganglion togethBr ~ith its postganglionic 
fib ers was isolated and a ligature pass·ec undern t.::i e.th the post-
ganglionic fiberso The responses of the nictttating membrane 
to electrical stimulation of the cervical sympathetic 
. . 
nerve were recorded on a Physiograph by means of a myograph 
B tr ansducer attached by silk thread, passing over a pulley 
to the nictitating membrane. The minimal intensity of 
electrical stimL!lation reeded to produce a contraction of the 
nictitating me~brane via stimulation of the pre- and post-
ganglioric sympathetic fib e rs ~as determinedo Th e test 
35 
compound was then administered. The pre- and postganglionic 
f ibers were stimulated during the effects of the drug as 
determinEd by changes in blood pressure. The blood pressure 
was allowed to return to normal& Responses of the nictitating 
membrane to pre- and postganglionic nerve stimulation were 
re-establi~h~d to insure the integrity of the preparationo 
b ) Results 
The results include the following: 
(1) ThG effects of 3-C2-I and 3-CB-Br on the 
nictitating membrane of the cat ( Table 13 ) . 
TABLE 13 . Effects of 3- be nz oyl - 1- ethylpyridinium iodide (3-~2 - I) and 3- benzo yl - 1-
octylpyridinium brom i de (3 - CB-Br) on the nictitating me~brane of the cat 
Animal Drug Dose Chan gB in Blood Pressure Response to Stimu l at ion of 
(mg/kg) % Change Cervical S~mgathatic Nerve a Ori(inal - Peak 
mm Hg) Pr egang lionic P o s t g an g 1 i on i .c 
1 3-C2 - I o.o 0- 0 0 ++ ++ 
10 . 0 120 - 60 - 50 0 ++ 
2 3- C2 - I O~O 0- 0 0 ++ ++ 
20.0 110- 70 - 36 + ++ 
3 3- C2 - I 0~0 0- 0 0 ++ ++ 
20.0 145- 90 ·-38 0 ++ 
4 3- C8 - Br o.o O·- 0 0 ++ ++ 
8 .0 180 - 120 - 33 0 ++ 
5 3- C8 - Br o.o O·- 0 0 ·}-+ ++ 
10 . 0 80 - 50 - 38 0 ++ 
a 
r ise; marked rise; 0' no change. Symbo l s : + ' + + , 
(.,J 
°' 
So Effects E.f. 3-Benzoyl-1-ethylpyridinium Iodide ( 3-C2-I ) 
and 3-Benzoyl-1-octylpyridinium Bro~ide (3-CB-Br) on 
t h.§,_ Hind Quarter Vasculature of the Int act Rat 
a) Experim ental Procedures 
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Male albino rats weighing 330 g to 430 g were anes-
thetiz ed with sodium pentobarbital, 35 mg/kg of a 3.5 percent 
solution, ad~inistered int raperitoneally. A midline incision 
was made from the pelvis to th e sternumo Th e intestines werE 
li fted cut of t he body cavit y and covered with qauze mcistened 
in normal s a lin e. Th e abdominal aorta and ven a cava were iso-
lated at the l eve l of the renel veins and li gated caudad to 
therno The aorta and ven a cava were cannu lated. 
The cannulat ed eorta was conn ected by gum tubing, 
capacity 6 ml, to a modified And ers on Craver 1 heart per-
fusion apparatuso The preparation was stabilized at a 
c onstant temperature of 35.5 degr ees centigrade, maintained 
by a circul ating water bath. A constant perfusion head pres 
sure of approximately 60 cm of wa ter was maintainedo Th e 
pe r fusion fluid was aerated Locke-Ringer solution. Du r ing 
each experiment the perfusate was collect ed and discarded. 
Hep arin sodium, Oo1 ml of a 1110 00 solution, was 
perf used through the preparation. When the perfusate was 
cl ear , the cocnting wa s begun. 
An electronic drop counter wa s used to r e cord the 
1Metro Industries, Lone Island City, New Yor k 
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rate of effluence. Following the recording of normal 
effluence, drug administration was effected via an injection 
spiral (1 .5 ml volume) connected to the perfusion c ana l ~ 
2.0 ml of perfusste was used to displace the drug. 
The experimental procedure was standardized with a 
2 minute control count$ When the volume of the effluent 
equaled the total volume of the tubing, a 4 minute drug 
effect count was tegunc The highest dose used was chosen 
to equal or exceed the intraperitoneal ED50 in ratso Th e 
high est dose used in the above experimsnts ~as also tested 
with a 15 minute drug effect interval and a 2 minute control. 
A two tailed Student 's t test was used to test the signifi-
cance of the data. 
Only one drug was used per animal. Not more than a 
total of 5 doses was administered per preparation. Each 
animal was used for a period not exceeding 2 hours, due to 
severe edema occurring after this period of time. 
b) Results 
The results include the followings 
(1) The effects of· 3-C2-I and 3-CB-Br on the hind 
quarter vascul a ture of the intact rat (T ables 14 and 15). 
TABLE 15. Effects of 3-benzoyl-1-octylpyridinium bromide (3-C8-Br) on the hind 
quarter vasculatur e of the intact rat 
Animal Dose Control Drug Effect pb 
Equivalent Drops/min. ± S.D. Drops/min~ .±. S.D. 
(mg) (mg/k g ) 
1 20 60.6 32.0 ± 2.0 37. 8 .±. 3.9 nos. 
20 60.6 35.0 .±. 1.0 41o0 .±. 9.,6 n.s. 
2 10 30.3 18.0 .±. 1.0 17.3 .±. 1o1 n.s. 
10 30.3 18.5 .±. 0.5 19.0 .±. 2.4 nose 
20 6006 17.1 .±. 1.0 19.5 .±. 1.1 n.s. 
3a 20 55.5 31.5 .±. o.s 39.0 .±. 6.1 n.s. 
20 55.5 47.0 .±. o.o 45.0 .±. 1.7 n.s. 
a Drug effect count taken f or 15 minutes after a 2 minute control counto 
b 
p ' 0 .01 S ymb ols: le ve l of si g~if ican ce; n .s., n ot s ignifi cant . 
b 
J::.. 
0 
TABLE 14. Effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I) on the hind 
quarter vasculature of the intact rat 
Animal Dose Control Drug Effect pb 
Equivalent Drops/Min. ± S.D. Drops/Min • .±. S.D. 
(mg) (mg/kg) 
1 10 23.,3 251,.0 .±. 1o0 247 .. 3 .±. 6.2 n.s. 
20 46.5 '132.0 .±. 10.0 121.0 .±. 5.3 n.s. 
2 5 13.0 84.0 .±. 1~ 0 E'i1-.3 .±. 2.6 nos. 
10 . 26.0 125.5 .±. 9.5 110.0 .±. 10.,7 n.s. 
20 52.0 123.5 .±. 1.5 124.0 .±. 11.°'7 n.s. 
3a 20 ::408 114.5 .±. 7.5 11207 .±. 3.6 n .. s. 
40 109 .. 6 71-oO .±. 5 ... 0 78.,6 .±. 3., 3 > 0. 05 
aDrug effect count taksn for 15 minutes after a 2 minute control count .. 
b Symbols : p ' 0.0 1 level of si gnificance; n.s., not significant. 
b 
(.,.J 
•..o 
6 . Effects of 3-Bi::nzoyl-1-ethylpyridir.ium Iodide ( 3-C2-I ) 
and 3-Benzoyl-1-octyloyridiniu~ Bromide \ 3-CB-Br ) on 
the Isolated Guinea £i..9. Heart 
a ) Experimental Procedures 
4 1 
GuinEa pigs of either sex weighin~ a50 q to 950 g 
were s~crificed by cervical dislocation~ FcJlowing a mid -
t horacic incision and retraction of the ribs, the heart was 
prepared as follows: 
\1) The descending aorta was clamped and cut distally 
in the are2 of . . thE diaphragm. 
\ 2 ) The major arteries, innominate, left subclavian, 
and left common carotid, were severed thus freeing the aortao 
( 3 ) The inferior and superior veriae cavae were severed~ 
( 4 ) The trachea was severed. 
The heart with lungs attached, was then rapidly 
removed and transferred to a dish of oxygenated perfusion 
solution at room temperature. Several ml of warm oxygenated 
~erfusion solution containing 0.1 ml of a 1:1000 solutior. of 
sodium heparin were gently passed through the coronary 
arteries via injection into the aorta to remove residual 
blood and to prevent formation of clots within these small 
blood vessels. The aorta was cannulated with a glass cannula 
with its tip proximal to the innominate artery and distal to 
the coronary ostia an~ SEcured. The cannulated heart was then 
transferred to an Anderson Craver heart perfusion apparatus. 
A constant fluid level was maintained in the perfusion well; 
the siphoned fluid was collected by means of suction and 
discarded. 
A constant temperature of 37~5 degrees cent igrade 
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was maintained by use of a ~irculating wEter bath. Following 
stabilization of the preparation under a perfusion head 
pressure of 55 cm of water, all extraneous tissue including 
the pericardium was dissected freso A stainless steel hook 
was inse rte d into the ven tricul ar musculature at the heart's 
apex and the glass ch ambe r secured. A silk thread connected 
the hook, through a pulley system, to a recording lever that 
recorded the cardiac contraction s on a slowly moving smoked 
kymograph. 
The perfusion solution used was that recommen ded by 
Ch enoweth and Koelle (1 946 ) modified by Smooklsr and Defeo 
(19 62 )0 
Fiv e liters of stock solution containin£ 350 g 
sodium chlorid e , 21o0 g pct ass ium chloride, 15.9 g calcium 
chlorid e dihydrate and 17. 8 g magnesium sulfate monohydrate 
were prepared using deionized water and stored at room 
temperat~r ee 
The fin al perfu s ion fluid ~as prepared for each 
experiment by taking 346 g dextrose, 4.2 g of sodium ticar-
bon ate , 200 ml of stoc~ solution and sufficient deionized 
water to make 2 liters of solution. Th e perfusion fluid 
was oxygenated with a mixture of 95 percen t oxygen and 5 
percent carbo n dioxid e o Th e pH of the final solution was 
70 80 During each experiment the perfusate was collected 
and discarded. 
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Followin g the recording of norm a l cardi ac contr a ctions 
drug administr a tion was effected via an injection spiral 
conn ected to the perfusion canal, with a volume of perfusate 
(2 .D ml) greater than that held by the spiral (1c 5 ml). 
One compound was tested per preparation and not more than 6 
injections were made on one pr e paration. Succeedin~ doses 
were adm i nistered after a lapse of 10 minutes from the time 
of rBcovery from the previou s doseo 
A depression of 95 percen t or more from the nor~al 
was considered to be ca rdiac arrest. A depression of 50 
to 95 perce nt was considered to be severe CGrd iac depression 
(SD), while 20 to 50 per~ent, mild cardiac depression (MD), 
0 to 20 percent, no eff~ct. Cardiac stimul a tion was con-
sider ed to have occurred if there was an increase of ampli-
tude of 50 percent over the normal. 
The indices of activity used to compare the compounds 
were as follo ws : 
(1) The incid e nce of c a rdiac arrest at a particular 
(2) The incidence and severity of cardi ac dep res s ion 
if no arrest occurred. 
(3) The incid ence of cardiac stimulation if no 
arrest occurred. 
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b) Results 
Th e results include the foll owing: 
(1) A profile of the effects of 3-C2-I and 3-CB-Br 
on the isolated guinea pig hec.r.t (Tables 16 and 17). 
( 2) 3-CB-Br. is c onsidered to be more toxic than 
3- C2 - I; at 2e0 mg, 3-CB-Br produced three out of three 
cardi ac arrests with no recoveries, while 3-C2-I at the same 
do se produced one out of seven cardiac arrests with no recov-
e r y an d fiv e out of seven se vere cardiac depressions with 
full recoveries. 
(3) In most trials resuJ.ting either i n cardiac 
arrest or severe depression, a 2 to 3 second int erva l of 
cardiac stimulation preced e d the former events. 
(4) In one experiment using 3-C2-I at 1.0 mg, 
there was one occurrence of cardiac stimulation only. 
(5) Employing 3-CB -Br there were 3 occurrences of 
card i ac stimulat ion only, two at 0.6 mg, and one at 1.0 mg. 
TABLE 16. Profile of the effects of 3-benzoyl-1-ethylpyridinium iodide (3-C2-I) on 
the isolated guinea pig hea~t 
Dose 
(mg/kg) 
0.02 
0.1 
0 .. 2 
0.5 
1. 0 
2.0 
4 .. 0 
Cardiac Arrest 
Arrests/Trials 
1/4 
1/7 
Recovery to 
50% Normal 
Recoveries / 
Arrests 
0/1 
0/1 
Cardiac Depression 
Depressions/Trials 
(if no arrest) 
1/2 SDa 
5/7 SD 
1/1 SD 
8 Symbol: SD, severe depression, 50-95 percent. 
bone occurrence of ca~diac stimulation, >50 ~ercent. 
Recovery to 
50% Normal 
R • I ecover1es; 
Depressions 
1/1 
5/5 
1/1 
No Effect 
No Effects/ 
Trials 
2/2 
1/1 
3/3 
1/1 
2/4b 
1/7 
J:>. 
Ul 
TABLE 17. Profile of the effects of 3-benzoyl-1-octylpyridinium bromide (3-CB-Br) 
on the isolated guinea pig heart 
· Dose 
(mg/kg) 
0.02 
o .. 2 
0.5 
0" 6 
1.0 
2.0 
20.0 
Cardia c Arrest 
Arrests/Trials 
1/5 
4/7 
3/5 
3/3 
1 /1 
Recovery to 
50% Norm3.l 
Recoveries/ 
Arrests 
1 /1 
2/4 
2/3 
0/3 
0/1 
Cardiac Depression 
Depressions/Trials 
(if no arrest) 
1/5 fYlDa 
1/1 soa 
1/7 MD 
1/5 SD 
Recovery to 
50% Normal 
Recoveries/ 
Depressions 
0/1 
0/1 
0/1 
0/1 
No Effect 
No Effects/ 
Trials 
1 /1 
3/5 
2/7b 
1/0 
c 
a.Symbols: SD, severe depression, 50-95 percent; MD, mild depression, 20-50 
percent. 
bTwo occurrences of cardiac stimulation, >50 percent increase. 
cOne occurrence of car diac stimula t ion, > 50 percent increase. 
J::>. 
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IV. DISCUSSION 
A. ACUTE TOXICITY STUDIES 
The acute ir.traperitoneal toxicity of several 
1-alkyl-3-benzoylpyridinium halides was determined in 
albino mice in order to test the possible existence of a 
trend in toxicity paralleling a change in structure. At 
the same time, the gross syndrome was Gbserved in order to 
provide information concerning a possible mode of action. 
The mEthyl salt6 of the 3 and o isomers wErE the 
least toxic end were comparab l e to each other. Toxicity 
increased with the ethyl salts of both isow ers , althou~h 
47 
the ethyl salt of the 4 isomer was 3 times more toxic th a n 
its counterp art. As the carbon substitution incre 2se d from 
two to seven carbons, the toxicity cf the 1-alkyl-3-benzoyl-
pyridinium halides decr eassdo From eight to Fifteen carbons 
the toxicity of th ese compou nds rapidly increas edo Physical 
changes in the co~pounds, decreasing water solubility and 
increasing ability of an aqueous solution to foam when 
agitated, paralleled the incr easing toxicity. 
Th e symptoms of toxicity appeared to be th e same in 
all cases: decreased activity, myuriasis, dyspnea, rapidly 
follo wed by convulsions ~nd death. The major change in 
toxicity was the period of time required for death or 
recov ery to occur. Compound s containing une to eight 
carbon s caused death or recovery in one hour, while 
compounds con taining nine to fifteen carbons re ~uired a 
24 to 48 hour period for death or recovery. 
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The ch ange from decr~asing to increasin£ toxicity 
paralleled by physical ch anges in the comp ound s and the 
~hang e in mortality time eccompanying the above, su gges t 
that ,there are t wo mechanisms of action for th ese compounds~ 
The fi rst occu rs with the compounds containing one to sevsn 
or eight carbonsa The second occurs with the compounds 
containing ~ore than eight carbons and may be due in part 
to surface active prop erties~ 
Based c~ certain pharmacolo~ical principles, three 
compoun ds representative of the 1-alkyl-3- benzo ylpyridinium 
halides were chosen for further study: 3-C2-I, 3-CB-Br, 
and 3-C1 5-Br~ Acut e intr aper iton ea l toxicities were 
determin e d in albino rats~ Although the gross syndrome 
was similar to that of ths mice, it was interest ing to note 
the apparent chang e in t he trend qf toxicitye 3- C2-I was 
three times more toxic in r ats whi le 3-CB-Br was two times 
more toxic in mice~ 
How e ve~, since only three com ~ounds had been tested 
in r 2ts , the possibility existed as in the mice that 
bet ween 3-C2-I and 3-CB-Br the toxicity might incr ease 
before decre asi ng. Th erefore, t wo more cow ~ounds, 3-C4-Br 
and 3-CS-Br, were each te ste d in 18 wale albinG r a ts 
em ploying thr ee do seso More dos es and l arger groups were 
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not employed due to the inavailability of sufficient amounts 
of the compcurds. These two compounds were less toxic th an 
3-C2-I, indicat ing that the trend in toxicity in both 
species was somewhat similar but occurr e d at a slightly 
differ ent number of carbonso 
B. BLOCD PRESSURE STUDIES-Rats 
Direct blood pressure studies were conducted in male 
albino rats because changes in blood pressure may indicate 
a dru~ action en the autonomic nervous system, on blood 
ves se ls, on the heart, or the central nervous syst Em4 
Intr avenous administration of 3-C2-I, 3-CS-Br, and 
3-C1 5-Br result e d in a rapid but transient hypot e nsion. 
Th e magnitude of the response v1as dose related while the 
duration of the response ·was dose related for the latter 
two compounds only. The order of increasing hypotensive 
effect was 3-C2-I, 3-CS-Br, and 3-C15-Br; the dur a tion of 
th e response also increa se d in this orderc 
The se compounds produced periods of dyspnea partic-
at hig her doses and in some instances, normal furction was 
restored with ~rtificial respiration. At higher doses of 
3-C15-Br, the respir at ory passages were - filled ~ith fluid 
and artificial respiration was in e ffectivE. This fluid 
phenomeron did not occur with the other compounds tested~ 
Respiratory f a il ure pr eceded cardia c arrest and death. 
c. BLO OQ. PRESSURI STUDIES-Ca~ and Doos 
Observati on of the hypote~sive effects cf these 
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compound s led to the investigation of the modo of this action. 
The pos sibility of a central action was not pursued because 
quaternary ammonium salts do not readily traverse the blood 
brain barrier. Therefore, investigation of thE hypotensive 
effects of thess compounds ~as directed toward peripheral 
actions. 
The first possible site of actior inv estigated was 
the autonomic nervous system, since this system exerts a 
signifi cant controlling influence on blood pressure. Four 
cardiovascular tests, mediated through the autonomic nervous 
system, were performed in cats1 carotid occlusion, vagal 
stimulation, administration of acetylcroline and epinephrine. 
Carotid occlusion reflexly stimulates the sympathetic nerve 
leadi ng to the heRrt through a central mechanism, which then 
caus es acceleration~ The blood vessels also constrict and 
a rise in blood pressure ensueso Electrical stimulation of 
the peripheral portion of the severed vagus nerve is a 
presynpatic stimulation of E parasympathetic nerve~ whose 
impul ses cause the heart rate to decrease End blood vessels 
to dilate. A fall in blood pressure ensues. Acetylcroline 
causes a fall in blooc pressure, epinephrine a rise in 
blood pressure, due to their actions at the neuro-effector 
junction of the parasympathetic syste~ a nd sympethetic 
system, respectively~ 
Concurrert to the pe a k hypotensive Effect of 3-C2-I 
or 3-C8-Br, the resporses to carotid occlusi on and vagal 
stimu l ation were either decreased or abolishEd. In most 
ins tances th8 respons e to epinephrine was incre 2sed . Thi s 
su ggested that the hypotersive effects of th ese twc com-
po unds resclted from the i nterference of trans mission at 
autonomic ganglia. 
r espect. 
3-C8-Br was more effecti ve in this 
In travenous administration of 3-C15-B7 t~ c2ts 
r esulted in death from r esp iratory failure probably due 
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in part to large 2mounts of red flui d in the respiratory 
pa ssages~ Aspiration of the fluid and artificial respira-
tio r were not effective. It was possible that this secretion 
of fluid might be the re s ult of excessive use of acetyl-
cholin e. Therefore, two additional cats were prepared by 
th e samE surgical procedu re but were administered only 
th e test compound. Th e same response was noteda 3-C12-Br 
was t ested in this manner with th e same resultso Wi th all 
fo ur compounds , respiratory failure preced ed car diac 
arre st and death. 
Some of t he high er molecular weight quaternary 
ammonium s a lts are surface active agents and hav8 found 
use as antibacterial agents (j isinfecta~ts, artiseptics , 
or sanitizers). Sinc e zqueous solutions of 3 C12-Br and 
3-C15-Br produce foam when ag itated , i t suggests that 
t hese two compounds have similar prop2rties. It is 
po ssib l e that the excess fluid in the respiratory passages 
resulted from an effect on- membra~e per~eability concomitant 
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with a hemolysis of red blood cells. 
A~thcugh 3-C12-Br and 3-C15-Br exhibited hypotensive 
effects preceding the appearance of fluid in the respiratory 
passages, no pcsitive conclusions u:ere drawn concerning 
their ~echanism of action. Fur th er study of these compounds 
was discontinued at this time. 
D. NICTITA TI NG MEMBRAN E 
The nict1tating membrane is a th~rd e yelid present 
in certain animals. It is composed of smooth muscle and 
is innervated by sympathetic fibers, only. The pre- and 
postganglionic fibers inn er va ting this membrane Gre re a dily 
isolated, thereby making it an id ea l pr e para tion for test-
ing sympathclytic and ganglioplegic agent s. 
Prior testing ha d suQgested that 3-C2-I and 3- CB-Br 
might be ganglioplegic agents. This preparation was 
employed to further test this sGpposition. 
3-C2-I and 3-CB-Br were found to be hypoten~ive 
agents when administered intravenously to cats. The 
increasin g hypot en sion was accompanied by a decreased and 
finally abolished re s ponse of the nictitating membrane to 
stimulation of the preganglionic cervical Eym pathe tic 
nerve. The return of tlood pressure to normal was accompa-
nied by a recovery of the response of the nictitating 
membrane to preganglioric stimulation. The response to 
postganglionic stimulation was unaffected. Th ese obser-
vations support the hypoth esis that the~e two compounds 
exsrt a hypotensive effect through ganglioplegia . 
E. filNDQLJARTER PERF-USION 
Although previous tests had shown that 3-C2-I 
and 3-CB-Br have ganglioplegic properties , these 
procedures had not esta~lished wheth8r direct va sodilation 
comprised a p~ssible o~ significant component o~ the 
hypotensive effect. ln order to test for vasodilator 
activity , ~i~dquarter parfusions wece performed in intact 
rats. The method employed permitted direct contact of the 
compounds with the hindquarter vasculature but precluded 
reflex control of the autonom ic nervous system. Th~s 
any change in flow rate would be due to a direct drug 
action upon the vasculature. 
The compounds were employed in doses up to the 
equivalent ED5D. A two tailed Student's t test at the 
9S per.cent level rejected the hypothesis of a signif i-
cant change in flow rate following ~ntravenous admi n-
istration of the test compound. Thus these axperim~nt s 
reject direct vasodilation as a significant component o~ 
the hypo~ensive effect. 
F. ISOLATED HEART PERFUSION 
Prio_ experimentat ion had estab li shed that 3-C2-I 
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and 3-CB-Br exerted a hypotensive effect resulting from 
ganglio~legia unabetted by significant direct vasodilation. 
However, the possibility of a direct action upon the heart 
contributin~ significantly to the hypotensive effect existed 
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and was tested by employing an isolated hear£ preparation . 
Perfusion of the coronary systeLl of an isolated heart has 
the advantags of supplying the drug direct ly to the cardiac 
muscle. Howsver, this method is disadvantageous becEuse of 
the inability to correlate the dose producing an effect on 
the isolated heart with the dose producing an effect in the 
intact an im a l. It can establish whether there is a depres-
sant effect but not whether the cc.rdiac depression contrib--
uted significantly to the overall hypotensive effect. 
The principal ef fect of 3-C2-I on the i solated heart 
was severe depression occurring from 0.5 to 4.0 mg . The 
principal effect of 3-CB-Br on the isolated heart was cardiac 
srrest occurring from 0.6 to 1.0 mg . At 2~0 mg the compound 
tecame cardiotoxic. Neither the magnitude nor the duration 
of the respo~se to either compound were dose related. 
Evaluated on the basis of c2rdiotoxicity , 3-CB-Br was 
more toxic than 3-C2-Io At 2.0 mg , the former produced 
three out of three cardiac arrests with no recoveries , 
while the latter at the same dose prod~ced one out of 
seven cardiac arrests with no recovery and five out of 
ssven severe cardiac depressions with full recoveries. 
Also noted in severa l inst ances with these compounds was an 
initial increased amplitude of contraction, lasting 2 to 
3 seconds preceding cardiac depression or arrest . 
The results of these experimen ts indicated that 
these compounds have an effect on the heart. No positive 
conclusions were drawn concerning this mechanism of action 
or concerning the contributio~ a nd significance of these 
effects to the overcll hypotension . 
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V. SUMMARY AND CONCLUSIONS 
1 . A series of syntheti.c 1--alky'l-3- and 1-alkyl-4·· 
benzoylpyridinium halides · were screened for pharmacological 
act ivity with the purpose of relating such activit y to their 
structura l arrangement . An attempt was made to determine 
their mode of act iono 
2. In micG, the trend of the acute intraperitoneal 
toxicity for the 1- a lkyl-3- benzo ylpyridinium halides was 
biphasic. The methyl halides of the 3 and 4 isowers were 
found to be the l eas t toxic and comparable to eac h other . 
The toxicity of the ethy l halides of these isomers was 
incr ease d over that of the methyl halides, a lthough the 4 
isom er was three times more toxic than its counterpart. 
As the carbon subst itution incr eased to seven in the 3 
isomer, the toxicity decreased. Increasing carbon substi-
tution resulted in incr easing toxicity. This incr eas ing 
toxicity was paralleled by an increasing ability of aqueous 
solutions of these compounds to foam an d a decreasing wate r 
s olubility . 
3. In rats the acute i ntraperitorsa l toxicity de-
cre ase d as the carbon substitution increased fro~ two to 
five . From 3-C5-Br to 3-CB-Br, the toxicity rapi dly increased . 
4. In rats, the EDSO (h ypotensive ) increased from 
3-C2-I to 3-CB-Br to 3-C15-Br. A dose-effect relationship 
existe~ . Higher doses of 3-C15-Br resulted in death from 
respiratory failure, which may have been partly duG to 
fluid in the respiratory pass ages . 
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5. In cats and dogs , 3-C2-I and 3-CS-Br demonstrated 
hypotensive effects . The normal response to carotid occlu-
sion and vagal stimulation was decreased and the response to 
injected epineph rine was increased suggesting ganglioplegia . 
3-CE-Br was more potent than 3-C2-I in this ability . In 
cats, 3-C12-Br and 3-C15-Br in higher doses resulted in 
respiratory failure probably due to excessive amounts of red 
fluid in the respiratory passages. The ability of aqueous 
solutions of these compounds to foam suggests death resulted 
from a change in membrane permeability concomitant with a 
hemolysis of red blood cells. 
6. 3-C2-I and 3-CB-Br blocked the normal response 
of the nictitating membrane in cats to electrica l stimula-
tion of the preganglioric cervical sympathetic nerveo The 
response of this membrane to pcstganglionic electr ical 
stimulation was unaffected. 3-CS-Br was more potent in 
this abilit y than 3-C2-I . 
7. Employing doses up to the equiva l ent ED50 
( hypotensive) in rats did not affect the flow rate of 
perfusions of the hind quarter vasculature of the intact 
rat . 
8. These two compounds showad cardiodep ressant 
and cardiotoxic effects on the isolated guinea pig heart. 
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A dose-effect relationship was not apparent . 3-CB-Br was 
more potent then 3-C2-I . 
9. The results of these experiments support the 
hypothesis that 3-C2-I and 3-CB-Br exert a hypotensive 
effect through ganglioplegia unabetted by direct vaso-
dilationg A depressant action on the heart may contribute 
to the hypotension induced by ganglioplegia . 
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